June 17, 2009 (Toronto, Ontario) — Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can provide a more precise assessment of recurrence and outcome in ovarian cancer ...

Phase II trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Background: A phase II study assessing the activity of RAD001 (Afinitor) in ...

Swiss researchers have shown that machine-learning algorithms can assist fully automated FDG-PET lung cancer detection — even at simulated very low effective radiation doses of 0.11 mSv — and can do ...

A new retrospective study published in JAMA identified that tuberculosis and certain fungal infections in the lungs could hamper the efficient detection of lung cancer by FDG-PET imaging. A test used ...

In the initial staging of esophageal cancer, preoperative PET scan may be useful in detecting additional cases of metastatic disease before costly and toxic definitive therapy. Currently, 18F-FDG PET ...

Relapse of Hodgkin's lymphoma (HL) after autologous stem cell transplantation (ASCT): Prognostic factors in 462 patients registered in the database of the EBMT. Background: FDG-PET after two cycles of ...

A new proof of concept study has shown that an imaging technique more commonly used to assess cancer patients may also be of help in assessing disease and treatment effects in patients with ...

This study assessed the use of positron emission tomography (PET) in identifying and diagnosing solitary pulmonary nodules (SPNs). For this a decision analysis model was constructed, and three ...

Evaluating tumor response and predicting prognosis in patients with unresectable malignant pleural mesothelioma, using CT and FDG-PET/CT techniques. A recent research study evaluated the efficiency of ...

Reston, VA – Each year, 8,000 Americans are diagnosed with Hodgkin's disease, a cancer of the lymphatic tissue. In order to offer the best prognosis, doctors must not only provide the original ...